Welcome to our dedicated page for ACII news (Ticker: ACII), a resource for investors and traders seeking the latest updates and insights on ACII stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ACII's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ACII's position in the market.
Atlas Crest Investment Corp. II (NYSE: ACII) will hold a Special Meeting of stockholders on December 1, 2022, at 10:30 a.m. ET. Stockholders will vote on amending the Charter to allow the early redemption of public shares before December 30, 2022, due to the inability to complete a business combination by the automatic termination date of February 8, 2023. If approved, public shares will cease trading on December 1, 2022, and redemption process will start shortly thereafter. For further details, refer to the definitive proxy statement filed on November 10, 2022.
Atlas Crest Investment Corp. II (ACII) has filed a preliminary proxy statement to seek stockholder approval for amendments to its Certificate of Incorporation, allowing for the early redemption of all outstanding public shares and liquidation by December 30, 2022. This decision follows a thorough evaluation of over 130 potential business combinations, hindered by adverse market conditions and changes in U.S. tax law that could impact shareholder redemptions post-December 31, 2022. A special meeting will be held for stockholders to vote on these amendments.
Atlas Crest Investment Corp. II (NYSE: ACII.U) announced that starting March 29, 2021, holders of its initial public offering units can separately trade shares of Class A common stock (symbol: ACII) and warrants (symbol: ACII WS). The separation will not issue fractional warrants, only whole warrants will be available for trade. The original units will continue trading under ACII.U. This announcement follows the effective declaration of registration statements by the SEC on February 3, 2021. The offering was managed by Cantor Fitzgerald & Co.
Atlas Crest Investment Corp. II (NYSE: ACII.U) successfully closed an upsized IPO of 34,500,000 units at $10.00 each, raising gross proceeds of $345,000,000. The offering included 4,500,000 additional units from an over-allotment option exercised by underwriters. Each unit includes one share of Class A common stock and a warrant to purchase one share at $11.50. Trading commenced on February 4, 2021, with shares and warrants to be traded under symbols ACII and ACII.WS, respectively. Cantor Fitzgerald & Co. served as the sole book-running manager for the offering.
Atlas Crest Investment Corp. II (NYSE: ACII.U) has priced its initial public offering (IPO) of 30,000,000 units at $10.00 each, set to begin trading on February 4, 2021. Each unit includes one share of Class A common stock and a quarter warrant for purchasing additional shares at $11.50. The offering closes on February 8, 2021, pending customary conditions. Cantor Fitzgerald acts as the sole book-running manager and has a 45-day option for an additional 4,500,000 units for over-allotments. The registration statement was effective as of February 3, 2021.
FAQ
What is the market cap of ACII (ACII)?
